CSIMarket
 
Kezar Life Sciences Inc   (NASDAQ: KZR)
 

Kezar Life Sciences Inc's Suppliers Performance

KZR's Supply Chain




 
KZR Costs vs Sales of Suppliers Growth

• More on KZR Suppliers






Kezar Life Sciences Inc's Comment on Supply Chain


The company sources raw materials, intermediates, active pharmaceutical ingredients (API), and finished drug products for clinical trials from contract manufacturing organizations (CMOs). These CMOs are required to produce API and finished drug products in compliance with current Good Manufacturing Practices (cGMP) and applicable laws. The company also contracts third parties for filling, labeling, packaging, storage, and distribution of investigational drug products. Manufacturing agreements with CMOs include confidentiality and intellectual property provisions to protect proprietary rights related to zetomipzomib. If approved, zetomipzomib will be manufactured commercially by one or more CMOs in FDA-compliant facilities. Currently, zetomipzomib is administered as a lyophilized product reconstituted prior to patient administration, with plans for self-administration using a sterile vial-adaptor device upon commercialization.

Kezar Life Sciences Inc's Comment on Supply Chain


The company sources raw materials, intermediates, active pharmaceutical ingredients (API), and finished drug products for clinical trials from contract manufacturing organizations (CMOs). These CMOs are required to produce API and finished drug products in compliance with current Good Manufacturing Practices (cGMP) and applicable laws. The company also contracts third parties for filling, labeling, packaging, storage, and distribution of investigational drug products. Manufacturing agreements with CMOs include confidentiality and intellectual property provisions to protect proprietary rights related to zetomipzomib. If approved, zetomipzomib will be manufactured commercially by one or more CMOs in FDA-compliant facilities. Currently, zetomipzomib is administered as a lyophilized product reconstituted prior to patient administration, with plans for self-administration using a sterile vial-adaptor device upon commercialization.







KZR's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Kezar Life Sciences Inc 53.54 0.00 -45.23 9
SUBTOTAL 0.00 0.00 0.00 -


Sources: Kezar Life Sciences Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Kezar Life Sciences Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.